CHARACTRISTICS OF CYTOKINES, PHENOTIPIC FEATURES AND NEUTROPHILSPHAGOCYTOSIS ACTIVITY IN ASTHMATIC PATIENTS DURING EXACERBATION

Cover Page

Abstract


The aim of our study was to measure the level of IL -8, IL-6, IL-4, IL-17 depending on spontaneous or induced release by peripheral blood leukocytes in patients with bronchial asthma exacerbation with comparative analysis of asthmatics' blood neutrophils phenotypic features. The obtained data indicate that the level either pro-inflammatory or anti-inflammatory cytokines was increased in patients with asthma exacerbations and significant increase of concentration of CD45+CD66b+CD11b+ cells in comparing with healthy donors. We determined that during asthma exacerbation the concentration of CD45+, CD66b+, CD11b+ blood granulocytes almost doubled in comparing with healthy donors. Also there is a significant increasing of blood granulocytes' phagocytosis activity. We observed the elevated level of spontaneous production of inflammatory mediators. Moreover, the stimulation of cytokines synthesis and release in patients with asthma does not always lead to increase of induced level of cytokines in contrast to healthy donors.

ОСОБЕННОСТИ ЦИТОКИНОВОГО ПРОФИЛЯ, ФЕНОТИПА И ФАГОЦИТАРНОЙ АКТИВНОСТИ НЕЙТРОФИЛОВВ КРОВИ БОЛЬНЫХ БРОНХИАЛЬНОЙ АСТМОЙ В ПЕРИОД ОБОСТРЕНИЯ

T V Borisova

Email: vasilchikova12@yandex.ru

S I Sokurenko

Email: doctsok@yandex.ru

A V Karaulov

Email: drkaraulov@mail.ru

  1. Kips J.C., O'Connor B.J., Langley S.J., Woodcock A., Kerstjens H.A.M., Postma D.S., Danzig M., Cuss F., Pauwels R.A. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med. 2003;167(12):1655-9.
  2. Lloyd C. M. Hawrylowicz C. M. Regulatory T cells in asthma. Immunity. 2009 Sep 18;31(3):438-49
  3. Desai D., Brightling C. Cytokine and anti-cytokine therapy in asthma: ready for the clinic? Clinical and Experimental Immunology, 2009.158: 10-19.
  4. Boyton R.J., Altamann D.M. Asthma: New developments in cytokine regulation. Clin. Exp. Immunol. 2004;136:13-4.
  5. Сильвестров В.П., Караулов А.В. Иммунологическая недостаточность при заболеваниях органов дыхания (вопросы диагностики, патогенеза и лечения). Тер.арх., 1985, т. 57, №3, с. 3-9.
  6. Караулов А.В., Анисимова Н.Ю., Должикова Ю.И. и др. Спонтанная и индуцированная продукция цитокинов лейкоцитами периферической крови у больных бронхиальной астмой в стадии обострения// Российский биотерапевтический журнал. 2010. Т.9, №.4 С. 93-96.
  7. Bhupinder S Mann and Kian F Chung. Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy//Respiratory Research 2006, 7:59.
  8. Chung K.F., Barnes P.J. Cytokines in asthma. Thorax. 1999;54:825-857.
  9. Gibson PG, Simpson JL, Saltos N: Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001, 119:1329-1336.
  10. Park S.J., Lee Y.C. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir. Res. 2010;11:78-88.
  11. Culotta E, Koshland D. E. NO news is good news // Science. 1992. Vol. 258. P. 1862-5.

Views

Abstract - 144

PDF (Russian) - 112

Cited-By


PlumX


Copyright (c) 2013 Borisova T.V., Sokurenko S.I., Karaulov A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.